Bachem has announced investment across their site network, with new funding to improve production facilities at their Bubendorf, Vista and St Helens sites, along with a new site in Sisseln.
Medicover Genetics, an innovator in genetic diagnostics and laboratory enablement, has announced the integration of Element Biosciences’ AVITI sequencing system into its end-to-end genomics platform.
Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon, has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation in the United Kingdom (UK) for YESINTEK.
Selvita is the first contract research organisation (CRO) to license a Chemical Protein Stability Assay developed and patented by Medicines Discovery Catapult (MDC) to help identify and prioritise drug candidates faster.
Process industry software specialist, eschbach, has won the German Innovation Award for its use of artificial intelligence (AI) to drive productivity and efficiency in the chemical and pharmaceutical industries.
Lonza, a contract development and manufacturing organisation (CDMO), has announced the launch of its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.
Cinclus Pharma Holding has announced an agreement with Zentiva, a European pharmaceutical company, for the commercialisation and manufacturing of its lead asset, linaprazan glurate, in Europe.
After Lonza announced the collaboration with Ethris to develop spray-dried mRNA vaccines for Respiratory Disease Prevention, EPM spoke to Carsten Rudolph, co-founder, Ethris and Kim Shepard, director of advanced drug delivery at Lonza to learn more.
Shilpa Biologicals, a full-service contract development and manufacturing organisation (CDMO), announces the opening of a dedicated bioconjugation suite at its Dharwad site in India.
